Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-02-29

FDA Approved: BUSPIRONE HCL — Supplemental Application (Advagen Pharma Ltd)

View source ↗

Summary

FDA approved Advagen Pharma Ltd's supplemental application for Buspirone HCl (buspirone hydrochloride).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Buspirone HCl (Buspirone hydrochloride)

Snippet

SUPPL AP for BUSPIRONE HCL (BUSPIRONE HYDROCHLORIDE)